Mark L. Jacobson, Chief Operating Officer at Axsome Therapeutics, Inc. (AXSM), sold 95,478 shares at $84.26 ($8.0M) on 2024-08-09, disclosed to the SEC on 2024-08-09.
Scheduled sale ($8.0M) by Chief Operating Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $84.26 | 47,739 | $4.0M | 50.0% |
| 2 | $84.26 | 47,739 | $4.0M | 50.0% |
| Total | $84.26 avg | 95,478 | $8.0M | 100% |
| Filing → |
| AXSM | SELL | 2026-02-27 | $5.7M | — | Filing → |
| AXSM | SELL | 2025-09-22 | $1.2M | — | Filing → |
| AXSM | SELL | 2025-09-17 | $5.9M | — | Filing → |